Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Alivus Life Sciences Ltd.
₹1,007
Invest in ALIVUS with up to 2.50x margin.
Trade with MTF₹957.00
₹1010.00
₹819.00
₹1225.10
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 672.89 | 587.98 | 601.85 | 649.54 | 641.84 |
| Operating Expense | 441.62 | 408.81 | 429.54 | 451.11 | 451.54 |
| Operating Profit | 231.27 | 179.17 | 172.31 | 198.43 | 190.31 |
| Depreciation | 19.66 | 18.44 | 17.06 | 15.97 | 15.16 |
| Interest | 1.49 | 1.32 | 1.25 | 1.26 | 0.46 |
| Tax | 48.13 | 44.11 | 41.45 | 49.42 | 48.19 |
| Net Profit | 150.26 | 130.03 | 121.54 | 141.87 | 136.96 |
Research Type
Equity , Long Term
Buy Range
₹882 - ₹899
Target Price
₹1,077
Stop Loss
-
Target Date
26 Jan 27
Potential Returns
22.11 %
₹1007.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 74.9 | 74.9 | 74.9 |
| FII | 7.8 | 6.7 | 6.6 | 6.4 | 6.8 | 5.1 |
| DII | 4.2 | 4.9 | 5.2 | 5.6 | 5.5 | 7.1 |
| Public | 13 | 13.4 | 13.2 | 13 | 12.8 | 12.9 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 45.71 K | 93 K | 49.15% |
| Week | 42.88 K | 1.06 L | 40.42% |
| 1 Month | 40.76 K | 78.67 K | 51.81% |
| 6 Month | 67.44 K | 1.09 L | 62.12% |
Companies with no Debt
Benjamin Graham Value Screen
Strong Momentum: Price above short, medium and long term moving averages
Mid-range Performer (DVM)
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 01 Sep, 2025 | 5 | FINAL | 01 Sep, 2025 | Equity Share |
| 17 Oct, 2023 | 22.5 | INTERIM | 17 Oct, 2023 | Equity Share |
| 24 Mar, 2023 | 21 | INTERIM | 24 Mar, 2023 | Equity Share |
| 15 Sep, 2022 | 10.5 | FINAL | Equity Share | |
| 22 Nov, 2021 | 10.5 | INTERIM | 23 Nov, 2021 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,500 | ₹615 | ₹775 | ₹1,395 | ₹4,578 | ₹496.65 |
| % Change | -2.66% | 0.16% | -0.91% | -2.88% | 0.93% | 0.04% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹1,419.33 | ₹878.40 | ₹4,256.70 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹20.10 | ₹240.10 | ₹318.19 |
| PE TTM | - | - | 62.00 | 800.80 | 43.90 | 24.70 |
| 1 Year Return | 41.17 | 3.73 | 59.76 | -13.79 | -4.8 | 5.55 |
| ROCE | 30.24 | 34.78 | 34.76 | 3.26 | - | 11.27 |
Blue Jet Healthcare Ltd
₹ 355.30
+1.23%
Concord Biotech Ltd.
₹ 1025.00
+0.49%
Aarti Pharmalabs Ltd.
₹ 642.00
+1.09%
Piramal Pharma Ltd.
₹ 142.00
-0.36%
Acutaas Chemicals Ltd.
₹ 2102.70
-9.84%
Cohance Lifesciences Ltd.
₹ 307.95
-1.28%
Syngene International Ltd.
₹ 393.10
-0.83%
Alembic Pharmaceuticals Ltd.
₹ 655.10
-3.24%
Strides Pharma Science Ltd.
₹ 969.60
+0.62%
Granules India Ltd.
₹ 610.10
-2.87%
FDC Ltd.
₹ 334.75
+1.96%
Shilpa Medicare Ltd.
₹ 385.50
+2.88%
Jubilant Pharmova Ltd.
₹ 842.00
+3.12%
Natco Pharma Ltd.
₹ 1024.00
+2.21%
Caplin Point Laboratories Ltd.
₹ 1572.00
+0.12%
Neuland Laboratories Ltd.
₹ 12408.00
-1.63%
Marksans Pharma Ltd.
₹ 167.90
-0.08%
AstraZeneca Pharma India Ltd.
₹ 7810.00
-0.53%
Sanofi India Ltd.
₹ 3262.00
-0.01%
Procter & Gamble Health Ltd.
₹ 4789.00
-0.42%
Jeena Sikho Lifecare Ltd.
₹ 603.50
+2.51%
By signing up I certify terms, conditions & privacy policy